Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02688452 · ClinicalTrials.gov registry record · NA
Water Oxygenation and Brain Activity
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02688452 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 40 participants.
The verdict
NCT02688452, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The primary purpose of this interventional, placebo controlled, crossover, double blind, basic science exploratory study is to investigate whether there is a difference in brain electrophysiological oscillatory activity in healthy adults before and after oral consumption of water containing very small bubbles of oxygen (electrokinetically modified water).
Interventions
- DIETARY_SUPPLEMENT Control Unmodified Placebo Water
- DIETARY_SUPPLEMENT Electrokinetically modified water (EMW)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-12 |
| Est. Completion | 2017-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02688452
The ClinicalTrials.gov registry entry for NCT02688452 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Unmodified Placebo Water is the first listed.
NCT02688452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02688452 about?
NCT02688452 is a clinical study titled "Water Oxygenation and Brain Activity". The primary purpose of this interventional, placebo controlled, crossover, double blind, basic science exploratory study is to investigate whether there is a difference in brain electrophysiological oscillatory activity in healthy adults before and after oral consumption of water containing very sma...
What is the current status of trial NCT02688452?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-12. Estimated completion is 2017-07-01.
What interventions are being tested in trial NCT02688452?
The interventions under investigation include: Control Unmodified Placebo Water (DIETARY_SUPPLEMENT), Electrokinetically modified water (EMW) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02688452?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.